Catena Biosciences was founded in 2020 based on technology developed in the Francis and Doudna Labs at UC Berkeley. Their platform allows for the rapid coupling of proteins for the creation of novel therapeutics in autoimmune disorders, oncology, and vaccine development.

Biotechnology

Catena Biosciences

Marco Lobba

Saurabh Johri

Gregorio (Geo) Guillen

Geo Guillen

The Leadership Team at Catena Biosciences is responsible for steering the strategic direction of the company, overseeing operations, and driving innovation in the development of novel therapeutics. They leverage their collective expertise to foster collaboration, secure funding, and guide the integration of advanced biotechnologies into the therapeutic pipeline.

Leadership Team

About

Team members

Other teams at Catena Biosciences

Research and Development